5 Best High Tech Stocks To Invest In 2015

5 Best High Tech Stocks To Invest In 2015: Cytori Therapeutics Inc(CYTX)

Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical products and devices to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. Its principal products include the Celution family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzyme reagents, and related instrumentation. Its core product, the Celution System, provides physicians with clinical grade stem and regenerative cells for use in the cosmetic and reconstructive surgery market. The company also provides PureGraft, a consumable product that provides grafts for use in aesthetic body contouring procedures. In addition, it sells the StemSource family of products worldwide, including in the United States, for research, as well as for the cryopreservation and storage of ADRCs. It offers the StemSource System as a standalone product, or as a part of a comprehensive suite of systems, equipment, and protocols collectively referred to as a StemSource Cell Bank. Further, the company develops Celution System, which has completed two clinical trials for applications in cardiovascular disease, wound healing, gastrointestinal disorders, stress urinary incontinence, liver and renal disease, spinal disc degeneration, and pelvic health conditions. It has strategic development and manufacturing joint venture agreement, and other related agreements with Olympus Corporation. The company was formerly known as MacroPore Biosurgery, Inc. Cytori Therapeutics, Inc. was founded in 1996 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By James E. Brumley]

  If you're reading this, then odds are you already know tha! t Cytori Therapeutics Inc. (NASDAQ:CYTX) is up a whopping 8% today. In some ways that's encouraging, as it proves there's a lot of trade-worthy momentum to be tapped. In other ways, however, it's bad, because CYTX is overbought and ripe for a pullback. No matter how you're seeing Cytori Therapeutics in the short run, though, when you take a step back and look at the longer-term picture, there's a lot to like.

• [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

  Cytori Therapeutics Inc.(CYTX) on Tuesday said it is putting a clinical hold on enrollment in two chronic-heart-failure clinical trials, citing safety concerns. Shares sank 32.9% to $1.41 premarket.

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/5-best-high-tech-stocks-to-invest-in-2015.html